BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25154323)

  • 1. Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas.
    Rau MK; Braun C; Skardelly M; Schittenhelm J; Paulsen F; Bender B; Ernemann U; Bisdas S
    J Neurooncol; 2014 Dec; 120(3):557-66. PubMed ID: 25154323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
    Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
    BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labelling perfusion in differentiating low-grade from high-grade brain tumours.
    Patil V; Malik R; Sarawagi R
    Pol J Radiol; 2023; 88():e521-e528. PubMed ID: 38125817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimenting with ASL-based arterialized cerebral blood volume as a novel imaging biomarker in grading glial neoplasms.
    Senger KPS; Kesavadas C; Thomas B; Singh A; Multani GS; An D; Label M; Suchandrima B; Shin D
    Neuroradiol J; 2023 Dec; 36(6):728-735. PubMed ID: 37548164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
    Kambe A; Kitao S; Ochiai R; Hosoya T; Fujii S; Kurosaki M
    J Neurooncol; 2024 Jan; 166(1):175-183. PubMed ID: 38165552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Yang S; Babb JS; Knopp EA; Golfinos JG; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study.
    Nguyen TB; Zakhari N; Velasco Sandoval S; Guarnizo-Capera A; Alexios Gulak M; Woulfe J; Jansen G; Thornhill R; Majtenyi N; Cron GO
    AJNR Am J Neuroradiol; 2023 Feb; 44(2):134-142. PubMed ID: 36702501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudocontinuous arterial spin labeling quantifies relative cerebral blood flow in acute stroke.
    Hernandez DA; Bokkers RP; Mirasol RV; Luby M; Henning EC; Merino JG; Warach S; Latour LL
    Stroke; 2012 Mar; 43(3):753-8. PubMed ID: 22343640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation Between High-Grade Glioma and Brain Metastasis Using Cerebral Perfusion-Related Parameters (Cerebral Blood Volume and Cerebral Blood Flow): A Systematic Review and Meta-Analysis of Perfusion-weighted MRI Techniques.
    Mohammadi S; Ghaderi S; Jouzdani AF; Azinkhah I; Alibabaei S; Azami M; Omrani V
    J Magn Reson Imaging; 2024 Jun; ():. PubMed ID: 38899965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists' Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging-An Institutional Experience.
    Yamin G; Tranvinh E; Lanzman BA; Tong E; Hashmi SS; Patel CB; Iv M
    AJNR Am J Neuroradiol; 2024 Apr; 45(4):453-460. PubMed ID: 38453410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.
    Ellika SK; Jain R; Patel SC; Scarpace L; Schultz LR; Rock JP; Mikkelsen T
    AJNR Am J Neuroradiol; 2007; 28(10):1981-7. PubMed ID: 17893216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.
    Zeng Q; Jiang B; Shi F; Ling C; Dong F; Zhang J
    AJNR Am J Neuroradiol; 2017 Oct; 38(10):1876-1883. PubMed ID: 28729293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of arterial spin labeling perfusion with dynamic susceptibility contrast perfusion in Moyamoya disease.
    Yadav N; Pendharkar H; Gupta AK; Prasad C; Shukla D; Kandavel T; Bansal S
    J Neurosci Rural Pract; 2023; 14(2):286-292. PubMed ID: 37181159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion.
    Lambrecht S; Liu D; Dzaye O; Kamson DO; Reis J; Liebig T; Holdhoff M; Van Zijl P; Qin Q; Lin DDM
    Brain Sci; 2024 Jan; 14(2):. PubMed ID: 38391701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
    Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
    Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods.
    Yamashita K; Togao O; Kikuchi K; Kuga D; Sangatsuda Y; Fujioka Y; Yoshimoto K; Ishigami K
    Neuroradiology; 2024 Feb; 66(2):187-192. PubMed ID: 38127124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR fingerprinting ASL: Sequence characterization and comparison with dynamic susceptibility contrast (DSC) MRI.
    Su P; Fan H; Liu P; Li Y; Qiao Y; Hua J; Lin D; Jiang D; Pillai JJ; Hillis AE; Lu H
    NMR Biomed; 2020 Jan; 33(1):e4202. PubMed ID: 31682305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnostic value of 3.0T MR 3D-ASL technique for recurrence and pseudo-progression of high-grade glioma.
    Chen YS; Zheng SY; Huang LL; Xu YG; Chen SQ; Zhan AL
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):679-686. PubMed ID: 38305610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry.
    Chakhoyan A; Yao J; Leu K; Pope WB; Salamon N; Yong W; Lai A; Nghiemphu PL; Everson RG; Prins RM; Liau LM; Nathanson DA; Cloughesy TF; Ellingson BM
    Sci Rep; 2019 Feb; 9(1):2846. PubMed ID: 30808879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion heterogeneity and vascular perfusion in tumor and peritumoral areas for prediction of overall survival in patients with high-grade glioma.
    Qiu J; Zhu M; Chen CY; Luo Y; Wen J
    Magn Reson Imaging; 2023 Dec; 104():23-28. PubMed ID: 37734575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.